Quaternized colestipol, an improved bile salt adsorbent: In vitro studies
Identifieur interne : 004760 ( Main/Exploration ); précédent : 004759; suivant : 004761Quaternized colestipol, an improved bile salt adsorbent: In vitro studies
Auteurs : S. Clas [Canada]Source :
- Journal of Pharmaceutical Sciences [ 0022-3549 ] ; 1991-02.
Abstract
Colestipol · HCI (col‐HCI) was quaternized with methyl iodide to form col‐CH3I. The in vitro binding capacities of the quaternized and protonated resins in water and in Tris‐HCl buffer (0.0015 and 0.0025 M, pH 7.0) at ∼22 °C for sodium glycocholate (NaGC) was determined by reversed‐phase HPLC. The binding capacities were found to depend on the adsorption medium. In water, the binding capacity of col‐CH3l was 30% greater than that of its protonated form. In Tris‐HCl buffer at pH 7.0, the binding capacities of the resins were similar. When the quaternized colestipol was converted to its chloride form, the binding capacity for NaGC in Tris‐HCl increased significantly and was 30% greater than that for its protonated analogue. In Cotazym 65B‐water, a medium used to test the binding capacity of the resins in the presence of various agents (to try to simulate intestinal conditions), the binding capacity of the quaternized resin was again greater than that of its protonated form. Quaternization thus increases the in vitro binding capacity of colestipol for the glycocholate anion.
Url:
DOI: 10.1002/jps.2600800208
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001508
- to stream Istex, to step Curation: 001508
- to stream Istex, to step Checkpoint: 001F54
- to stream Main, to step Merge: 005049
- to stream Main, to step Curation: 004760
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Quaternized colestipol, an improved bile salt adsorbent: In vitro studies</title><author><name sortKey="Clas, S" sort="Clas, S" uniqKey="Clas S" first="S." last="Clas">S. Clas</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1D1242D7FF6F2ADE03CA47947DD82C38DC08581E</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1002/jps.2600800208</idno><idno type="url">https://api-v5.istex.fr/document/1D1242D7FF6F2ADE03CA47947DD82C38DC08581E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001508</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001508</idno><idno type="wicri:Area/Istex/Curation">001508</idno><idno type="wicri:Area/Istex/Checkpoint">001F54</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001F54</idno><idno type="wicri:doubleKey">0022-3549:1991:Clas S:quaternized:colestipol:an</idno><idno type="wicri:Area/Main/Merge">005049</idno><idno type="wicri:Area/Main/Curation">004760</idno><idno type="wicri:Area/Main/Exploration">004760</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Quaternized colestipol, an improved bile salt adsorbent: In vitro studies</title><author><name sortKey="Clas, S" sort="Clas, S" uniqKey="Clas S" first="S." last="Clas">S. Clas</name><affiliation wicri:level="4"><country>Canada</country><wicri:regionArea>Department of Chemistry, McGill University, 801 Sherbrooke St. W., Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation><affiliation wicri:level="1"><country>Canada</country><wicri:regionArea>Current Address: Paprican, 570 St. John's Blvd. Pointe‐Claire, Quebec</wicri:regionArea><wicri:noRegion>Quebec</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Pharmaceutical Sciences</title><title level="j" type="abbrev">J. Pharm. Sci.</title><idno type="ISSN">0022-3549</idno><idno type="eISSN">1520-6017</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Washington</pubPlace><date type="published" when="1991-02">1991-02</date><biblScope unit="volume">80</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="128">128</biblScope><biblScope unit="page" to="131">131</biblScope></imprint><idno type="ISSN">0022-3549</idno></series><idno type="istex">1D1242D7FF6F2ADE03CA47947DD82C38DC08581E</idno><idno type="DOI">10.1002/jps.2600800208</idno><idno type="ArticleID">JPS2600800208</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-3549</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Colestipol · HCI (col‐HCI) was quaternized with methyl iodide to form col‐CH3I. The in vitro binding capacities of the quaternized and protonated resins in water and in Tris‐HCl buffer (0.0015 and 0.0025 M, pH 7.0) at ∼22 °C for sodium glycocholate (NaGC) was determined by reversed‐phase HPLC. The binding capacities were found to depend on the adsorption medium. In water, the binding capacity of col‐CH3l was 30% greater than that of its protonated form. In Tris‐HCl buffer at pH 7.0, the binding capacities of the resins were similar. When the quaternized colestipol was converted to its chloride form, the binding capacity for NaGC in Tris‐HCl increased significantly and was 30% greater than that for its protonated analogue. In Cotazym 65B‐water, a medium used to test the binding capacity of the resins in the presence of various agents (to try to simulate intestinal conditions), the binding capacity of the quaternized resin was again greater than that of its protonated form. Quaternization thus increases the in vitro binding capacity of colestipol for the glycocholate anion.</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Québec</li></region><settlement><li>Montréal</li></settlement><orgName><li>Université McGill</li></orgName></list><tree><country name="Canada"><region name="Québec"><name sortKey="Clas, S" sort="Clas, S" uniqKey="Clas S" first="S." last="Clas">S. Clas</name></region><name sortKey="Clas, S" sort="Clas, S" uniqKey="Clas S" first="S." last="Clas">S. Clas</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004760 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004760 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:1D1242D7FF6F2ADE03CA47947DD82C38DC08581E
|texte= Quaternized colestipol, an improved bile salt adsorbent: In vitro studies
}}
| This area was generated with Dilib version V0.6.29. |  |